Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA (MRK)

52
Real-time Quote. Real-time Tradegate - 03/06 06:07:31 am
98.435 EUR   +0.70%
03/03 PHYSIOMICS : Shares Surge As It Gets Contract With Merck
03/03DJGermany's Merck Cautious After Deal Spree -- Update
03/03DJMerck Profit Slips Despite Revenue Gains
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Merck KGaA May Withdraw Research from Portugal over Debt-Report

07/09/2012 | 02:28am US/Eastern

German chemical company Merck KGaA (>> Merck KGaA) may withdraw future investments for research projects in Portugal worth tens of millions of euros unless the government hospitals stick to the agreed-upon debt repayments, German daily newspaper Financial Times Deutschland reports Monday.

Merck Portugal's manager Fritz Sacher told the paper the company's research projects are long-term and require mutual trust as a basis. "The Portuguese government's lacking payment habits undermine this trust," he is quoted as saying.

Portuguese government hospitals owe the pharmaceutical industry a total of more than 1.5 billion euros ($1.84 billion) and companies have to wait nearly 550 days on average until invoices are paid, FTD reports.

Some companies, including Roche Holding AG (ROG.VX), have already halted the sale of medications on credit to highly indebted countries like Portugal, Greece, Spain and Italy until outstanding debts are paid, the paper notes, but for many companies such drastic steps are difficult as they carry responsibility for people's wellbeing.

Withdrawing research projects is a way of putting pressure on the government, as Portugal is an attractive location for research investments, FTD says. "The conditions for certain research and human studies are as good as in the U.S., but it's significantly more cost-effective in Portugal," Sacher told the paper.

Newspaper website: http://www.ftd.de

Write to the Frankfurt Bureau at djnews.frankfurt@dowjones.com

Stocks mentioned in the article : Merck KGaA
React to this article
Latest news on MERCK KGAA
03/03 PHYSIOMICS : Shares Surge As It Gets Contract With Merck
03/03DJGermany's Merck Cautious After Deal Spree -- Update
03/03DJMerck Profit Slips Despite Revenue Gains
03/03 MERCK KGAA : Finishes Year of Key Strategic Moves with Record Figures
03/03 Merck Finishes Year of Key Strategic Moves with Record Figures
03/03 MERCK KGAA : Threshold Pharmaceuticals Reports Fourth Quarter and Year End 2014 ..
02/27DJMerck KGaA 4Q 2014 -- Forecast
02/25 MERCK KGAA : Investigators at Merck Serono Report New Data on Immunoglobulins (R..
02/24 MERCK KGAA : Ralph R. Dammel from Merck receives the Frits Zernike Award for Mic..
02/23DJEUROPE MARKETS : Greek Bailout Extension Delivers Fillip To European Stocks
Advertisement
Chart
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF